21.10.0
Производство основных фармацевтических продуктов
152
Общество с ограниченной или дополнительной ответственностью
03877
Агентство по развитию фармацевтической отрасли при Министерстве здравоохранения Республики Узбекистан
1724401
Республика Узбекистан, Сырдарьинская область, Гулистан
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
No data on participation in public procurement as a supplier or customer
Коротко о компании
OMONMEDFARM has been operating since 2019 in the "Производство основных фармацевтических продуктов" industry. The director is RADJABOV DJAMOLULLAX ZIYADULLAYEVICH. The company belongs to the "Small business" category. Its primary activity is "Производство основных фармацевтических продуктов". The company has 1 founders, one of whom owns a 100% stake. The company has 4 licenses, confirming the broad scope of permitted activities in "Производство основных фармацевтических продуктов".. The company holds property totaling 2 units, is included in 0, and has 15 similar companies, indicating a developed competitive market.
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
4
1
3
0
No data on trademarks
Коротко о компании
OMONMEDFARM has been operating since 2019 in the "Производство основных фармацевтических продуктов" industry. The director is RADJABOV DJAMOLULLAX ZIYADULLAYEVICH. The company belongs to the "Small business" category. Its primary activity is "Производство основных фармацевтических продуктов". The company has 1 founders, one of whom owns a 100% stake. The company has 4 licenses, confirming the broad scope of permitted activities in "Производство основных фармацевтических продуктов".. The company holds property totaling 2 units, is included in 0, and has 15 similar companies, indicating a developed competitive market.